Doctors are being urged not to implant recalled BioZorb tissue markers in any new patients, and to closely monitor those who have received the implants.
Lawsuits allege recalled BioZorb Markers failed to absorb after breast cancer treatments, resulting in painful complications and need for additional surgery.
Manufacturer will remove all remaining BioZorb Markers from the market, following adverse events and lawsuits filed by women who experienced problems with the breast tissue implant.
Following years of hormonal birth control shots, intracranial meningiomas developed that required repeated surgeries and radiation treatments to remove the brain tumors.
Indiana woman indicates that side effects of Depo-Provera shots caused a large meningioma to develop, alleging Pfizer failed to adequately warn about the brain tumor risks.
Each of the women experienced severe complications from the BioZorb implant, after the radiographic marker failed to dissolve, migrated or fractured
FDA warns that problems with BioZorb Marker can cause users to suffer severe and potentially life-threatening complications from the bioabsorbable radiographic markers used for breast care and other exams
Most rectal cancer patients who only received pre-surgical chemotherapy for locally advanced tumors were disease free after five years
Researchers were surprised to find an inverse dose effect, meaning the risks of cardiovascular disease actually increased at very low doses of radiation.
More than one-in-10 women who received left-side breast cancer radiation therapy (RT) develop heart disease within the following three decades.
